Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-15
1999-01-05
Stockton, Laura L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546173, A61K 3147, C07D21512
Patent
active
058563369
ABSTRACT:
A compound of the formula ##STR1## Z=--CH(OH)--CH.sub.2 --CH(OH)--CH.sub.2 --COO.1/2Ca have HMG--CoA inhibiting effects, making them useful as inhibitors of cholesterol biosynthesis. The compound may be prepared as a pharmaceutical for reducing hyperlipidemia, hyperlipoproteinemia or atherosclerosis.
REFERENCES:
patent: 5753675 (1998-05-01), Wattanasin
Fujikawa Yoshihiro
Iwasaki Hiroshi
Kitahara Masaki
Sakashita Mitsuaki
Suzuki Mikio
Nissan Chemical Industries Ltd.
Stockton Laura L.
LandOfFree
Quinoline type mevalonolactones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline type mevalonolactones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline type mevalonolactones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-862588